Atenol

Quick links to important sections

Atenol

Selected form

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Atenol

Quick Facts

Property Description
Active ingredient Atenolol
Form Oral tablet (Solid dosage form)
Pharmacological class Beta-blocker (beta-adrenergic receptor antagonist)
Common use Systemic cardiovascular stabilization
Origin Synthetic compound

What Type of Medicine is Atenol (Atenolol)?

Atenol is a prescription-only, synthetic medication classified as a Beta-blocker, which is used to influence and stabilize activity within the cardiovascular system. Its sole active ingredient is the generic compound Atenolol (chemical formula C14H22N2O3), which confirms its classification as a member of the beta-adrenergic receptor antagonist drug class, focusing on the reduction of sympathetic nervous system effects. This drug is a single-ingredient product, focusing entirely on the action of Atenolol, and its role in medicine for managing cardiovascular functions is clinically recognized.

Cardioselectivity and Physical Form

Atenolol is characterized as a beta-1-cardioselective antagonist, meaning it primarily targets receptors found in the heart, and it is most commonly administered as an oral tablet. This specific cardioselectivity is a key differentiating feature; it allows the drug to act predominantly on beta-1 receptors in cardiac tissue with reduced impact on beta-2 receptors located in other systems, such as the bronchi. This preferential targeting is an important property in its functional profile. The medicine is presented as an oral solid dosage form, typically a film-coated tablet, ensuring convenient and controlled daily oral administration through the digestive tract.

General Purpose and Therapeutic Benefit

The general purpose of Atenol is to reduce strain on the heart muscle, stabilize heart function, and help maintain lower blood pressure by moderating the effects of stress hormones. Atenolol works by dampening signals that would otherwise cause the heart to beat faster and contract more forcefully. This mechanism achieves the critical therapeutic benefit of decreasing the heart muscle's overall oxygen demand by reducing its workload. By consistently mediating these physiological actions, Atenol provides foundational support and stabilization, which is typically used in the long-term management of chronic cardiovascular concerns.

What side effects are possible with Atenol?

Possible Side Effects and Safety Information

The official safety profile for Atenolol, a beta-blocker, structures documented risks according to frequency and affected body systems, derived from regulatory prescribing information.

Frequency-Classified Adverse Reactions

The most frequently documented reactions are classified as Common, affecting up to 1 in 10 patients. These include tiredness (fatigue), bradycardia (slow heart rate), cold extremities, and general gastrointestinal disturbances . Less common and Rare effects are also documented across multiple systems, such as thrombocytopenia (low platelet count), psychoses, and sleep disturbances.

System-Organ Class Groupings and Serious Risks

Adverse effects are categorized by the physiological system involved. Cardiac disorders are central, with documented risks including the worsening of pre-existing heart failure and the precipitation of second or third-degree heart block. Vascular disorders often manifest as hypotension and the aggravation of peripheral circulatory disturbances.

Safety Constraints and Special Populations

Official labeling defines several limitations on use. Atenolol is contraindicated in patients with conditions such as uncontrolled heart failure, cardiogenic shock, or severe bradycardia. A documented safety concern is the risk of exacerbation of angina or myocardial infarction if the medicine is abruptly discontinued (abrupt cessation risk), especially in patients with coronary artery disease. Specific safety notes exist for patients with renal impairment, as clearance is reduced, and for pregnant patients, due to the potential for fetal harm like low birth weight.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes Atenol overexposure primarily through the lens of severe physiological depression, affecting the cardiovascular and respiratory systems.

Documented Overdose Manifestations

System Clinical Signs and Symptoms (Documented in Labeling)
Cardiovascular Severe bradycardia (slow heartbeat), hypotension (low blood pressure), dizziness, fainting (syncope).
Other Bronchospasm, lethargy, confusion, and the risk of masked or prolonged hypoglycemia.

Severe Outcomes and Emergency Action

An overdose is documented to potentially escalate into life-threatening conditions, including the precipitation of second- or third-degree heart block or cardiogenic shock. Due to the severity of these potential outcomes, regulatory guidance mandates specific emergency actions.

Immediate medical attention must be sought following any suspected overdose. Emergency services must be contacted immediately if the affected individual has collapsed, experienced a seizure, exhibits severe trouble breathing, or cannot be awakened. Management in a hospital setting is symptomatic and supportive, addressing hypotension and bradycardia with specialized intravenous treatments and, where necessary, using supportive procedures such as a transvenous cardiac pacemaker or hemodialysis. There is no specific antidote documented in the official prescribing information.

Therapeutic Uses of Atenol

What Atenol Treats: Main Uses and Benefits

Atenolol provides therapeutic support for several primary cardiovascular domains, focusing on stabilization and symptomatic relief related to heart function and blood pressure. Its use is focused on addressing chronic and recurrent conditions to support general well-being during symptomatic phases and functional comfort. The medication helps address groups of symptoms related to systemic imbalance and heightened physiological activity.

Management and Symptomatic Relief

The medication is commonly used to help with the management of symptoms linked to systemic imbalance, and may assist with easing the overall symptom load. When managing angina, it provides supportive relief when symptoms interfere with routine activities by helping to address the impact of these episodic manifestations.

“This therapy is relevant for easing symptoms linked to organ-specific functional stress, particularly when rhythm disturbances lead to irregular or excessively rapid heart rate.”

In relevant clinical contexts, it is commonly used to help with heart rate and rhythm stabilization, and assists with maintaining functional stability for patients requiring this kind of cardiovascular support.


Quick Fact: Symptom Management Focus

Property Description
Primary Therapeutic Use Long-term support for chronic hypertension
Symptom Relief Focus Recurrent chest discomfort in stable angina
Clinical Benefit Supports functional stability during symptomatic episodes

Regulatory References

  1. NIH MedlinePlus Drug Information on Atenolol

Eligibility and Restrictions for Use

Atenol (Atenolol) is an eligible treatment primarily established for use in the adult population. The medicine's official eligibility profile is strictly defined by regulatory documents, which establish clear restrictions for specific clinical conditions and demographic groups.

Populations Who Must Not Use Atenol (Contraindicated)

Official labeling mandates that Atenol is contraindicated in patients with:

  • Severe Bradycardia (very slow heart rate) or Sick Sinus Syndrome.
  • Second or Third-Degree Heart Block.
  • Overt or Uncontrolled Cardiac Failure.
  • Cardiogenic Shock.
  • Severe Peripheral Circulatory Disturbances.
  • Known Hypersensitivity to atenolol or its components.

Eligibility Restrictions and Cautions

Use is restricted in several populations due to physiological considerations or data limitations:

  • Renal Impairment: Use requires dosage adjustment because the drug accumulates when kidney function is severely impaired (creatinine clearance below 35 mL/min).
  • Age Groups: Use is not established and generally not recommended for the pediatric population. Older adults may require a reduced starting dose.
  • Pregnancy and Lactation: Use during pregnancy is not recommended due to documented risks, including fetal growth restriction. It passes into breast milk, requiring caution due to the risk of infant bradycardia and hypoglycemia.

What should I know about interactions with other medicines?

Atenol’s interaction profile is primarily defined by documented restrictions and additive cardiovascular effects, as established in regulatory labeling. The co-administration of Atenol with certain Calcium Channel Blockers, such as intravenous Verapamil or Diltiazem, is restricted due to the high risk of severe bradycardia and profound hypotension from combined cardiodepressant effects. A mandatory timing rule requires that neither drug be administered intravenously within 48 hours of discontinuing the other.

Several medicinal products may potentiate the primary pharmacodynamic effects of Atenol. Combining the drug with Cardiac Glycosides (e.g., Digoxin) or other Anti-arrhythmic Drugs (e.g., Amiodarone) may increase the risk of bradycardia and impact cardiac conduction time. Co-administration with other anti-hypertensive agents or alcohol can result in additive hypotensive effects. The official label notes a specific restriction involving Clonidine, where its abrupt withdrawal while on Atenol carries a documented risk of severe rebound hypertension.

Interactions also involve alterations to exposure. Aluminum and calcium hydroxide-containing antacids may reduce Atenol’s absorption, lowering plasma concentration. Conversely, Atenol exposure can be increased in individuals with impaired renal function due to the drug’s reliance on kidney clearance. For patients taking Insulin or Oral Antidiabetic Drugs, Atenol may intensify the blood sugar-lowering effect and mask key cardiovascular signs of hypoglycemia.

Mechanism of Action

How Atenol Works


Selective Modulation of Heart Rate and Contractility

Atenolol is a selective beta1-Adrenergic Receptor antagonist that acts primarily on the heart's conduction system and muscle tissue. By occupying these receptor sites, the drug competitively blocks stimulating signals from Norepinephrine, interfering with Sympathetic Nervous System signaling. This initial molecular action results in a decrease in the rate of impulse generation (Negative Chronotropy) and a decrease in contractility (Negative Inotropy). This reduced cardiac activity directly lowers the heart muscle’s total Myocardial Oxygen Demand.


Suppression of the Renal Neurohormonal Cascade

The drug's mechanism extends to neurohormonal regulation through its beta1-receptor action on the kidney’s juxtaglomerular apparatus. Blockade at this site suppresses the release of Renin, the initial step in the Renin-Angiotensin-Aldosterone System (RAAS). This pathway modulation influences systemic hemodynamics by altering the downstream effects of this neurohormonal cascade.


Pure Peripheral Pharmacological Profile

Atenolol is characterized by the lack of Intrinsic Sympathomimetic Activity (ISA), confirming its status as a pure blocking agent without partial activation. Additionally, its hydrophilic nature restricts its ability to cross the Blood-Brain Barrier, ensuring the physiological effects are predominantly confined to the peripheral cardiovascular and renal systems, establishing a defined mechanistic profile.

Dosage and Administration Information

Atenolol is administered primarily via the oral route as a tablet for chronic maintenance, although an intravenous injection is officially used for early intervention in the immediate hospital phase following a heart event. The tablets are generally taken once daily at the same time each day and may be consumed with or without food. Dose adjustments are typically evaluated after one to two weeks of consistent therapy.

The official dosing regimen is dependent on the condition. For hypertension, the starting dose is usually 50 mg once daily, with a maintenance dose typically ranging up to 100 mg per day. For angina pectoris, the daily dose may range from 50 mg to 100 mg, which can be taken as a single dose or divided into two. In older adults, a lower starting dose, such as 25 mg daily, should be considered.

Dosing in renal impairment is mandatory, as the medicine is primarily cleared by the kidneys. For patients with a Creatinine Clearance (CrCl) between 15–35 mL/min, the maximum oral dose is restricted to 50 mg daily. If a regular dose is missed, it should be taken as soon as remembered, but must be skipped if it is almost time for the next scheduled dose. Treatment must not be stopped suddenly; clinical guidelines specify a gradual dose reduction (tapering) over a period of 7–14 days.

Recent Clinical Evidence

Atenol: Recent Clinical Evidence

Recent clinical research on Atenol (atenolol) continues to confirm its established use as a beta1-selective adrenergic blocking agent. Evidence primarily supports its role in the management of hypertension (high blood pressure), angina pectoris (chest pain), and in the secondary prevention following myocardial infarction (heart attack).


Key Findings from Meta-Analyses

Systematic reviews have investigated Atenol's long-term effect on cardiovascular outcomes in patients with primary hypertension. A significant finding across meta-analyses is that while Atenol effectively lowers blood pressure, it may not consistently reduce the risk of stroke or overall mortality in certain patient groups, particularly those over 60 years old, compared to newer classes of antihypertensive agents. This has prompted closer examination of its role in treatment guidelines.


Pharmacokinetic Research and Safety Profile

Research has provided consistent data on Atenol's pharmacokinetics, noting its low lipid solubility and limited ability to cross the blood-brain barrier, which is associated with a reduced incidence of central nervous system (CNS) side effects compared to non-selective beta-blockers.

  • Elimination: Atenol is predominantly excreted unchanged by the kidneys. This factor necessitates careful monitoring and dosage adjustment in individuals with impaired renal function, a finding strongly supported by recent studies.

  • Tolerability: Common reported adverse events often relate to the reduction in cardiac activity, including bradycardia (slowed heart rate), dizziness, and fatigue. Peripheral coldness is also a commonly reported observation.

Key Studies & References

  1. Re-examining the efficacy of $beta$-blockers for the treatment of hypertension: a meta-analysis (CMAJ, 2006)
  2. Atenolol - StatPearls (for general indications and safety profile)
  3. Drugs for acute coronary syndrome / STEMI and secondary prevention of MI (Atenolol in secondary prevention)

Frequently Asked Questions (FAQ)

Common questions about Atenol (FAQ)

Q: How long does Atenol usually stay active in the body?

Studies documented in official sources indicate that the drug's primary effect of blocking beta-receptors can still be measured more than 24 hours after a single oral dose. This duration of activity is consistent with its established use for once-daily administration.

Q: Is Atenol the same drug as Tenormin?

The active ingredient in Atenol is the generic compound atenolol. According to the official patient information provided by regulatory bodies, the most common brand name for this drug is Tenormin.

Q: Can Atenol interact with ibuprofen or other NSAIDs?

Regulatory documents state that co-administration of Atenol with nonsteroidal anti-inflammatory drugs (NSAIDs) may affect its action. NSAIDs, such as ibuprofen, may reduce the blood pressure-lowering effect that Atenol is intended to provide.

Q: Is it safe to consume energy drinks while taking Atenol?

Official information indicates that excessive caffeine use may need to be addressed while taking this medication. Caffeine, a primary ingredient in energy drinks, can increase heart rate and blood pressure, which may counteract Atenol's intended effects and reduce its ability to lower blood pressure.

Q: Is Atenol appropriate for long-term use?

Official documents describe Atenol as a foundational medicine typically used in the long-term management of chronic cardiovascular conditions. Its established role is to provide continuous support and stabilization for concerns such as hypertension and angina pectoris.

Q: Are there any known issues with taking Atenol if you have asthma?

Atenol is officially contraindicated in patients who have severe asthma or severe chronic obstructive pulmonary disorders (COPD), which represents a restriction for its use. While Atenol is a cardioselective drug, it may occasionally cause some increase in airways resistance.

Q: Can Atenol affect a person's mood or lead to depression?

Official safety information lists depression as a potential side effect that may occur while taking this medication. Rare changes in mood are also documented in the psychiatric disorders category of the official safety profile.

Q: Does taking Atenol cause problems with sexual function?

Official safety documents list a decrease in sexual ability, desire, drive, or performance as a possible side effect. Impotence, or the inability to have or keep an erection, is also documented in the official safety labeling.

Q: What signs indicate a person might be having an allergic reaction to Atenol?

Atenol may cause hypersensitivity reactions, which are reported to include certain signs. These signs can include angioedema (swelling, typically of the face or throat) and urticaria, commonly known as hives or rash.

Q: Are there specific foods that should be avoided when on Atenol?

Official information indicates that certain common fruit juices may reduce the amount of Atenol absorbed by the body. These include grapefruit, apple, and orange juices, and may lead to a lower concentration of the drug in the bloodstream.

Q: Can Atenol make exercise feel harder or more difficult?

As a drug that works by reducing the heart's rate and contractility, Atenol can decrease the body's capacity for maximal and endurance exercise. This reduction in cardiac activity may be perceived by the patient as making physical activity feel harder or more difficult.

Q: Is it necessary to monitor heart rate while taking Atenol?

Atenol reduces the heart rate as a result of its core mechanism. Official documents note that if the pulse rate drops below 50–55 beats per minute at rest and the patient develops symptoms related to a slow heart rate, official guidance notes the need for an evaluation of the dosage.

Q: Is Atenol a medication that can cause a cough?

Official safety reports list cough as a less common side effect associated with the use of Atenol. Cough, if experienced, is a finding that is typically discussed during follow-up with a healthcare provider.

Q: Does Atenol commonly cause nightmares or vivid dreams?

Nightmares are documented as a rare side effect in official safety documents. Other sleep and dream disturbances, including vivid dreams, are also documented in the official safety profile, though their frequency may not be determined.

Q: Is Atenol officially classified as a drug that affects the liver?

Official safety information documents rare instances of hepatic toxicity (liver injury) and elevations of liver enzyme levels (transaminases) in patients taking Atenol.

Q: Are patients on Atenol restricted from certain activities, like driving?

Official patient information includes a warning about driving or operating heavy machinery until the effects of the medication on coordination and judgment are known. This caution is issued because Atenol may affect reaction time or judgment.

How should Atenol be stored and disposed of?

Storage and Disposal of Atenolol Tablets

Atenolol tablets must be stored according to specific regulatory conditions to maintain their stability.

Storage Requirements

Atenolol should be stored at controlled room temperature, which is officially defined as 20 C to 25 C (68 F to 77 F). The medication must be kept in the container it came in, with the container tightly closed, and protected from both excess heat and moisture.

It is prohibited to freeze the medication. The product must also be stored out of the reach of children.

Disposal Instructions

Unused or expired Atenolol must be disposed of according to local requirements and regulations. Consumers are advised to consult their healthcare professional or pharmacist on the appropriate method for discarding medicine no longer needed, and to avoid flushing it down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Atenol found in:

A-Z Index: